Amgen Complaint Against Roche Accepted By ITC
This article was originally published in The Pink Sheet Daily
Executive Summary
The U.S. International Trade Commission has agreed to review Amgen's complaint against Roche regarding Roche's importation of pegylated recombinant human erythropoietin, Amgen announced May 9